Cover Image

Cause‐Specific Mortality and Prognostic Impact of Comorbidity in Japanese Patients With Chronic Lymphocytic Leukemia

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Daisuke Ikeda, Takuya Nunomura, Tsuyoshi Muta, Kosei Matsue
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Cancer Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real‐World Impact of Cardiovascular Adverse Events
by: Mavis Obeng‐Kusi, et al.
Published: (2025)

Effect of Statins in the Watch and Wait Phase of Chronic Lymphocytic Leukemia
by: David E. Spaner
Published: (2025)

Efficacy and Effectiveness Outcomes of Treatments for Double‐Exposed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients: A Systematic Literature Review
by: Mohammed Zuber, et al.
Published: (2024)

Incidence, Prevalence, Survival and Mortality of Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma and Waldenström Macroglobulinaemia in Australia
by: Dieu Nguyen, et al.
Published: (2026)

Adverse Effects of Low Serum HDL ‐C Levels on Prognosis and Tumor Immune Microenvironment in Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
by: Weiran Lv, et al.
Published: (2026)

CSF3R Mutations Imply Adverse Prognostic Impact in Adult Acute Myeloid Leukemia Patients: A Single‐Center Retrospective Study
by: Jinjun Yang, et al.
Published: (2025)

Inflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients During Treatment With Bosutinib
by: E. Agostani, et al.
Published: (2025)

Second Cancer Incidence and Cause‐Specific Mortality in Primary Gastrointestinal Non‐Hodgkin Lymphoma Survivors: A Population‐Based Cohort Study
by: Jiahe Wu, et al.
Published: (2025)

Assessment of Treatment Outcome in Chronic Myelogenous Leukemia Patients on Tyrosine Kinase Inhibitors: Insight From a Resource Limited Setting
by: Wude Yewondwosen Awlachew, et al.
Published: (2025)

Prognostic Value of Deep Learning‐Extracted Tumor‐Infiltrating Lymphocytes in Esophageal Cancer: A Multicenter Retrospective Cohort Study
by: Peishen Li, et al.
Published: (2025)

Machine Learning–Driven Prognostic Model Integrating Lymphocyte‐to‐C‐Reactive Protein Ratio and TNM Staging in Gallbladder Cancer
by: Mingyang Wang, et al.
Published: (2026)

Clinical Features and T‐Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC ‐ TFR Study
by: Hiroshi Ureshino, et al.
Published: (2025)

Lymphocyte activation markers predict the therapeutic response to immune checkpoint inhibitors: A case–control study
by: Takuya Iwamoto, et al.
Published: (2024)

Prognostic Nomograms and Scoring System: Novel Approaches to Forecast Overall Survival and Cancer‐Specific Survival in Patients With Testicular Cancer
by: Xiaoqi Huang, et al.
Published: (2026)

Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population
by: Minji Jung, et al.
Published: (2024)

A Novel Prognostic Risk‐Scoring Model Based on RAS Gene‐Associated Cluster in Pediatric Acute Myeloid Leukemia
by: Cai‐Ju Luo, et al.
Published: (2025)

Electronic Patient‐Reported Outcome Quality of Life Score in Japanese Patients With Pancreatic Cancer on Second‐Line Chemotherapy: A Multicenter Observational Study
by: Yuki Takumoto, et al.
Published: (2025)

The impact of deprivation on colorectal cancer‐stage distribution in a setting with high hospital bed density: A Japanese multilevel study
by: Toshiaki Shibata, et al.
Published: (2024)

Diagnostic and Prognostic Significance of Exosomes and Their Components in Patients With Cancers
by: Zinnat Ara Moni, et al.
Published: (2025)

Circulating CD3 + CD8 + T Lymphocytes as Indicators of Disease Status in Patients With Early Breast Cancer
by: Han‐Kun Chen, et al.
Published: (2025)

Multi‐Omic Analysis Reveals the Impact of Bortezomib in Hyperleukocytic Acute Myeloid Leukemia
by: Jinxian Wu, et al.
Published: (2024)

The Association Between Psychological Distress, Emergency Room Visits, and All‐Cause Mortality Among Colorectal Cancer Survivors
by: Pranali G. Patel, et al.
Published: (2025)

C‐Reactive Protein to Lymphocyte Ratio (CLR) and Lactate Dehydrogenase to Albumin Ratio (LAR) as Prognostic Biomarkers in Acral Melanoma: Association With Tertiary Lymphoid Structures and Immune Cell Infiltration
by: Donglin Kang, et al.
Published: (2025)

Prognostic Implications of Thrombocytopenia in Chinese Patients With Newly Diagnosed Multiple Myeloma
by: Xiaojing Li, et al.
Published: (2025)

Resilience Development Among Adult Patients With De Novo Acute Leukemia: A Qualitative Study
by: Danyang Li, et al.
Published: (2024)

Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B‐Cell Precursor Acute Lymphoblastic Leukemia
by: Yuta Katai, et al.
Published: (2025)

Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients
by: Valentina Salvestrini, et al.
Published: (2025)

Clinical Characteristics, Gene Mutation Profiles and Prognosis of Patients With Acute Myeloid Leukemia Carrying PHF6 Mutations
by: Dongmei Wang, et al.
Published: (2026)

Hypothyroidism as Prognostic Factor in Cutaneous Melanoma: A 1553‐Patient Single‐Center Study
by: Julie Klose, et al.
Published: (2026)

Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative ( HR +/ HER2 −) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study
by: Debu Tripathy, et al.
Published: (2026)

Identification of Prognostic Risk Factors in Older Patients With Extensive‐Stage Small Cell Lung Cancer
by: Jiayin Liu, et al.
Published: (2026)

Low Testosterone Level and Mortality Risk in Patients With Prostate Cancer: A Post‐Randomization Analysis
by: Sayeh Fattahi, et al.
Published: (2025)

Impact of High Serum Lysozyme Activity on Renal Function and Survival Outcomes in Transplant‐Eligible and Ineligible Acute Myeloid Leukemia
by: Takafumi Tsushima, et al.
Published: (2026)

Differences in Tumor‐Infiltrating Lymphocyte Counts in the Peritumoral Area in Patients Undergoing Hepatic Resection After Lenvatinib and Atezolizumab Plus Bevacizumab Therapy for Hepatocellular Carcinoma
by: Katsuya Toshida, et al.
Published: (2025)

Prognostic Factors in Patients With Locally Advanced Hypopharyngeal Squamous Cell Carcinoma After Radical Radiotherapy/Chemoradiotherapy
by: Xinyue Qu, et al.
Published: (2025)

Correction to “Real‐World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL ‐Chile Study”
Published: (2025)

Mapping of Functional Metabolic Phenotypes in Acute Myeloid Leukemia
by: Sissel Dyrstad, et al.
Published: (2025)

DGKα Enhances Tumorigenic Activity in Bladder Cancer Patients With Chronic Kidney Disease
by: Kenshiro Takemoto, et al.
Published: (2025)

Clinical Characteristics, Prognostic Factors and Therapeutic Strategies in Gastric Cancer Patients With Bone Metastasis: A Retrospective Analysis
by: Shiji Ren, et al.
Published: (2025)

Prognostic Role of Hemoglobin Combined With Geriatric Nutritional Risk Index in Patients With Vater Ampulla Carcinoma Undergoing Pancreaticoduodenectomy
by: Jieping Ying, et al.
Published: (2024)